Normalizing effects of modafinil on sleep in chronic cocaine users

American Journal of Psychiatry

Volumn 167, Issue 3, 2010, Pages 331-340

  Morgan, Peter T ^a   Pace Schott, Edward ^a   Pittman, Brian ^a   Stickgold, Robert ^a   Malison, Robert T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; MODAFINIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MORNING DOSAGE; MULTIPLE SLEEP LATENCY TEST; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SCORING SYSTEM; SLEEP; SLEEP TIME; SLOW WAVE SLEEP;

ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP DISORDERS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME; WAKEFULNESS;

EID: 77649178110     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09050613     Document Type: Article

References (49)

1. Breslau N, Roth T, Rosenthal L, Andreski P: Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996; 39:411-418
2. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006; 59:1052-1060
3. Le Bon O: Contribution of sleep research to the development of new antidepressants. Dialogues Clin Neurosci 2005; 7:305-313
4. Monnelly EP, Ciraulo DA, Knapp C, LoCastro J, Sepulveda I: Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 2004; 24:532-535
5. Landolt HP, Gillin JC: Sleep abnormalities during abstinence in alcohol-dependent patients: aetiology and management. CNS Drugs 2001; 15:413-425
6. Brower KJ, Aldrich MS, Hall JM: Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 1998; 22:1864-1871
7. Brower KJ: Insomnia, alcoholism and relapse. Sleep Med Rev 2003; 7:523-539
8. Krystal A: Sleep and psychiatric disorders: future directions. Psychiatr Clin North Am 2006; 29:1115-1130
9. Morgan PT, Malison RT: Cocaine and sleep: early abstinence. ScientificWorldJournal 2007; 7:223-230
10. Gawin FH, Kleber HD: Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry 1986; 43:107-113
11. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS: Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: a controlled, residential study. Arch Gen Psychiatry 1990; 47:861-868
12. Gillin JC, Pulvirenti L, Withers N, Golshan S, Koob G: The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. Biol Psychiatry 1994; 35:843-849
13. Johanson CE, Roehrs T, Schuh K, Warbasse L: The effects of cocaine on mood and sleep in cocaine-dependent males. Exp Clin Psychopharmacol 1999; 7:338-346
14. Kowatch RA, Schnoll SS, Knisely JS, Green D, Elswick RK: Electroencephalographic sleep and mood during cocaine withdrawal. J Addict Dis 1992; 11:21-45
15. Pace-Schott E, Stickgold R, Muzur A, Wigren P, Ward AS, Hart CL, Clarke D, Morgan A, Hobson JA: Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacology 2005; 179:873-883
16. Thompson PM, Gillin JC, Golshan S, Irwin M: Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol Psychiatry 1995; 38:831-836
17. Watson R, Bakos L, Compton P, Gawin F: Cocaine use and withdrawal: the effect on sleep and mood. Am J Drug Alcohol Abuse 1992; 18:21-28
18. Morgan PT, Pace-Schott EF, Sahul ZH, Coric V, Stickgold R, Malison RT: Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: evidence for occult insomnia. Drug Alcohol Depend 2006; 82:238-249
19. Morgan PT, Pace-Schott EF, Sahul ZH, Coric V, Stickgold R, Malison RT: Sleep architecture, cocaine and visual learning. Addiction 2008; 103:1344-1352
20. Morgan PT, Paliwal P, Malison RT, Sinha R: Sex differences in sleep and sleep-dependent learning in abstinent cocaine users. Pharmacol Biochem Behav 2009; 93:54-58
21. Roehrs T, Johanson CE, Meixner R, Turner L, Roth T: Reinforcing and subjective effects of methylphenidate: dose and time in bed. Exp Clin Psychopharmacol 2004; 12:180-189
22. Roehrs T, Papineau K, Rosenthal L, Roth T: Sleepiness and the reinforcing and subjective effects of methylphenidate. Exp Clin Psychopharmacol 1999; 7:145-150
23. Kampman KM: The search for medications to treat stimulant dependence. Addict Sci Clin Pract 2008; 4:28-35
24. Morgan PT, Malison RT: Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence. Am J Drug Alcohol Abuse 2008; 34:692-702
25. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP: A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005; 30:205-211
26. Black JE, Hirshkowitz M: Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 2005; 28:464-471
27. Czeisler CA, Walsh JK, Roth T, Hughes RJ, Wright KP, Kingsbury L, Arora S, Schwartz JR, Niebler GE, Dinges DF; US Modafinil in Shift Work Sleep Disorder Study Group: Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med 2005; 353:476-486
28. Moldofsky H, Broughton RJ, Hill JD: A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Med 2000; 1:109-116
29. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ: Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 2006; 319:561-569
30. Mignot E, Nishino S, Guilleminault C, Dement WC: Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994; 17:436-437
31. Mitchell HA, Bogenpohl JW, Liles LC, Epstein MP, Bozyczko-Coyne D, Williams M, Weinshenker D: Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. Pharmacol Biochem Behav 2008; 91:217-222
32. Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y: Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 2008; 28:8462-8469
33. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K: Effects of modafinil on dopamine and dopamine transporters in the male human brain. JAMA 2009; 301:1148-1154
34. Ballon JS, Feifel D: A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 2006; 67:554-566
35. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM: Assessment of alcohol withdrawal: the Revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 1989; 84:1353-1357
36. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193-213
37. Sobell L, Maisto S, Sobell M, Cooper A: Reliability of alcohol abusers' self-reports of drinking behavior. Behav Res Ther 1979; 17:157-160
38. Morgan PT, Malison RT: Chest tightness and palpitations associated with modafinil and consumption of free glutamate. Am J Psychiatry 2008; 165:538
39. Iber C, Ancoli-Israel S, Chesson A, Quan S (ed): The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, Ill, American Academy of Sleep Medicine, 2007
40. Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Daniel LL, Bailey D, Berry RB, Kapen S, Kramer M; Standards of Practice Committee of the American Academy of Sleep Medicine: Practice parameters for clinical use of the Multiple Sleep Latency Test and the Maintenance of Wakefulness Test. Sleep 2005; 28:113-121
41. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S: Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep 1986; 9:519-524
42. Ellis BW, Johns MW, Lancaster R, Raptopoulos P, Angelopoulos N, Priest RG: The St Mary's Hospital Sleep Questionnaire: a study of reliability. Sleep 1981; 4:93-97
43. Coffey SF, Dansky BS, Carrigan MH, Brady KT: Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms. Drug Alcohol Depend 2000; 59:277-286
44. Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC, Grebow PE: A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999; 39:30-40
45. Van Dongen HP, Maislin G, Mullington JM, Dinges DF: The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26:117-126
46. Ferrara M, De Gennaro L, Bertini M: Selective slow-wave sleep (SWS) deprivation and SWS rebound: Do we need a fixed SWS amount per night? Sleep Res Online 1999; 2:15-19
47. Walsh JK, Randazzo AC, Stone K, Eisenstein R, Feren SD, Kajy S, Dickey P, Roehrs T, Roth T, Schweitzer PK: Tiagabine is associated with sustained attention during sleep restriction: Evidence for the value of slow-wave sleep enhancement? Sleep 2006; 29:433-443
48. Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Funderburk FR, Cadet JL, David PM, Verdejo-Garcia A, Benbrook AR: Sleep disturbance in heavy marijuana users. Sleep 2008; 31:901-908
49. Nishino S, Mao J, Sampathkumaran R, Shelton J: Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online 1998; 1:49-61